The Efficacy of Glecaprevir/Pibrentasvir in Chronic Hepatitis C Patients and the Impact of the COVID-19 Pandemic: Multicenter Real-Life Data
Glecaprevir/pibrentasvir is a highly effective and relatively safe drug in the treatment of chronic hepatitis C. The COVID-19 pandemic has negatively affected the follow-up and treatment processes of patients. New measures are needed for the follow-up and treatment of patients with chronic hepatitis C during pandemics.
Authors
- Neşe Demirtürk (ORCID: https://orcid.org/0000-0002-6186-2494)
- Şua Sümer (ORCID: https://orcid.org/0000-0003-3508-7516)
- Duru Mıstanoğlu Özatağ (ORCID: https://orcid.org/0000-0002-0005-192X)
- Aysel Kocagül Çelikbaş (ORCID: https://orcid.org/0000-0002-7448-5210)
- Faruk Karakeçili (ORCID: https://orcid.org/0000-0002-7368-7187)
- Mehmet Reşat Ceylan (ORCID: https://orcid.org/0000-0001-8063-4836)
- Bilgehan Aygen (ORCID: https://orcid.org/0000-0002-7598-6578)
- Sevil Alkan (ORCID: https://orcid.org/0000-0003-1944-2477)
- Yunus Gürbüz (ORCID: https://orcid.org/0000-0002-8772-0769)
- Mehmet Çelik (ORCID: https://orcid.org/0000-0002-0583-929X)
- Nazlım Aktuğ Demir (ORCID: https://orcid.org/0000-0002-4703-0827)
- Petek Konya (ORCID: https://orcid.org/0000-0001-5055-1220)
- Nefise Öztoprak (ORCID: https://orcid.org/0000-0001-6382-2229)
- Umut Devrim Binay (ORCID: https://orcid.org/0000-0003-3841-9109)
- Şengül Üçer (ORCID: https://orcid.org/0000-0002-1764-3198)
- Nevin İnce (ORCID: https://orcid.org/0000-0002-0129-4536)
- Ayşe Batırel (ORCID: https://orcid.org/0000-0002-6005-636X)
- Anıl AKÇA (ORCID: https://orcid.org/0000-0001-5029-9838)
- Sabahat Çeken (ORCID: https://orcid.org/0000-0002-3679-0978)
- Sami KINIKLI (ORCID: https://orcid.org/0000-0002-9661-7851)
- Güle Çınar (ORCID: https://orcid.org/0000-0002-7635-8848)
- Dilek YEKENKURUL (ORCID: https://orcid.org/0000-0002-4456-7485)
- Veli Günay (ORCID: https://orcid.org/0000-0001-9151-0636)
- Orhan Yıldız (ORCID: https://orcid.org/0000-0001-6019-0430)
- Arif Doğan Habiloğlu (ORCID: https://orcid.org/0000-0001-8122-8768)
- Zahide Aşık-Otman (ORCID: https://orcid.org/0000-0002-1729-2922)
Institutions
- Çanakkale Onsekiz Mart Üniversitesi (TR)
- Ministry of Health (TR)
- Selçuk University (TR)
- Ankara University (TR)
- Erzincan Binali Yıldırım University (TR)
- Hitit Üniversitesi (TR)
- Dr Lütfi Kırdar Kartal Eğitim ve Araştırma Hastanesi (TR)
- Ankara Onkoloji Eğitim ve Araştırma Hastanesi (TR)
- Antalya Eğitim ve Araştırma Hastanesi (TR)
- Sağlık Bilimleri Üniversitesi (TR)
- Afyonkarahisar Sağlık Bilimleri Üniversitesi
- Afyon Kocatepe University (TR)
- Düzce Üniversitesi (TR)
- Harran University (TR)
- University of Health Sciences Antigua (AG)
- Erciyes University (TR)
Publication Details
- Journal
- Infectious Diseases and Clinical Microbiology
- Published
- 2024-09-26
- DOI
- https://doi.org/10.36519/idcm.2024.344
- Citations
- 1
- Primary Topic
- Hepatitis C virus research
- Type
- article
- Field-Weighted Citation Impact
- 0.37